logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > Manidipine Dihydrochloride CAS 89226-75-5

Manidipine Dihydrochloride CAS 89226-75-5

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 89226-75-5

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/P,T/T,D/A,MoneyGram,Western Union

Supply Ability: G,KG,TON

Get Best Price
Highlight:
Appearance::
White To Pale Yellow Solid
CAS NO::
89226-75-5
Molecular Formula::
C35H39ClN4O6
Molecular Weight::
647.16000
EINECS NO::
680-304-3
MDL NO::
MFCD00896434
Appearance::
White To Pale Yellow Solid
CAS NO::
89226-75-5
Molecular Formula::
C35H39ClN4O6
Molecular Weight::
647.16000
EINECS NO::
680-304-3
MDL NO::
MFCD00896434
Manidipine Dihydrochloride CAS 89226-75-5

Product Description:

Product Name: Manidipine Dihydrochloride CAS NO: 89226-75-5


Synonyms:

4-(diphenylmethyl)-1-piperazinyl)ethylmethylester,dihydrochloride;

cv-4093dihydrochlorde;

franidipinehydrochloride;


Chemical & Physical Properties:

Appearance: White to pale yellow solid

Assay :≥99.00%

Boiling Point: 722℃ at 760 mmHg

Melting Point211℃ (dec.)

Water Solubility: Soluble in DMSO. Slightly soluble in water and ethanol /n

Storage: Refrigerator

Solubility: DMSO (Sparingly, Heated), Methanol (Slightly)


Safety Information:

HS Code: 2942000000

RIDADR: UN 2811 6.1/PG III

RTECS: US7975300

Hazard Class: 6.1

Packing Group: III


Manidipine Dihydrochloride is a metabolite of Manidipine (M16400), a dihydropyridine calcium channel blocker that exhibits antihypertensive properties. Manidipine 2Hcl (CV-4093) is a dihydropyridine compound and a calcium channel blocker for Ca2+ current with IC50 of 2.6 nM. IC50 value: 2.6 nMTarget: calcium channelManidipine is described to block T-type Ca2+ channels specifically and is also described to have a high selectivity for the vasculature, presenting negligible cardiodepression as compared to other Ca2+ channel antagonists. Manidipine is also described to not significantly affect norepinephrine levels, suggesting a lack of sympathetic activation with this compound. Manidipine reduces pro-inflammatory cytokines secretion in human endothelial cells and macrophages. Manidipine, unlike other third-generation dihydropyridine derived drugs, blocks T-type calcium channels present in the efferent glomerular arterioles, reducing intraglomerular pressure and microalbuminuria.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.